About Apnimed
Apnimed is a private company based in Cambridge, Massachusetts. It has reported $284,325,535 raised in nine offerings on Form D since July 2018. Its chief executive is Kevin Lind.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Mar 11, 2026 | Mar 27, 2026 | $24,999,994fully sold | 2 | $12.4M | EquityRule 506(b) | Form D ↗ |
| Sep 17, 2025 | Sep 24, 2025amended Dec 8, 2025 | $35,000,000fully sold | 7 | $5.0M | Debt, Securities on exerciseRule 506(b) | Form D/A ↗2 earlier filings |
| Apr 23, 2025 | Apr 24, 2025 | $16,499,982fully sold | 3 | $5.4M | EquityRule 506(b) | Form D ↗ |
| Nov 1, 2023 | Nov 8, 2023 | $0of $37.4M target | 1 | $0 | EquityRule 506(b) | Form D ↗ |
| Dec 22, 2022 | Dec 23, 2022 | $79,749,950fully sold | 6 | $13.2M | EquityRule 506(b) | Form D ↗ |
| Apr 28, 2022 | May 10, 2022amended Nov 1, 2022 | $62,499,913fully sold | 14 | $4.4M | EquityRule 506(b) | Form D/A ↗1 earlier filing |
| Mar 12, 2021 | Mar 25, 2021 | $24,999,982fully sold | 3 | $8.3M | EquityRule 506(b) | Form D ↗ |
| Mar 31, 2020 | Apr 7, 2020 | $15,000,000fully sold | 1 | $15.0M | EquityRule 506(b) | Form D ↗ |
| Jun 25, 2018 | Jul 6, 2018amended Aug 7, 2019 | $25,575,714fully sold | 12 | $2.1M | EquityRule 506(b) | Form D/A ↗3 earlier filings |
| Total, nine offerings | $284,325,535 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Apnimed's Form D filed Mar 27, 2026.
Earlier filings also listed Michael Rogers (executive officer, last listed Nov 2023), Stefan Larson (director, last listed Dec 2022), Ruoxi Hu (director, last listed Dec 2022), Rosy Hu (director, last listed Nov 2022), James Galeota (director, last listed Nov 2022), Gerald Chan (director, last listed Mar 2021) and Ron Farquhar (director, last listed Apr 2020).
Sources
- SECApnimed, Inc. Form D/A, filed Oct 1, 2025
- SECApnimed, Inc. Form D, filed Sep 24, 2025
- SECApnimed, Inc. Form D, filed May 10, 2022
- SECApnimed, Inc. Form D/A, filed Jan 10, 2019
- SECApnimed, Inc. Form D/A, filed Aug 9, 2018
- SECApnimed, Inc. Form D, filed Jul 6, 2018
- SECApnimed, Inc. filing history
- CompanyPrivacy policy
- CompanyContact
- PressFDA acceptance of AD109 application